SEC Says Health Care Co. Lied About COVID-19 Readiness

By Adam Lidgett · July 7, 2021, 6:17 PM EDT

A health care company has been accused in New York federal court by the U.S. Securities and Exchange Commission of leading stakeholders astray by issuing allegedly misleading proclamations about COVID-19 screening...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

United States Securities and Exchange Commission v. Parallax Health Sciences, Inc. et al

Case Number

1:21-cv-05812

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

July 07, 2021